Almac Partners with Merck KGaA and the MRC to Assess Markers of Response to Cetuximab Therapy

News   Apr 15, 2010

 
Almac Partners with Merck KGaA and the MRC to Assess Markers of Response to Cetuximab Therapy
 
 
 

RELATED ARTICLES

Researchers Test Drug Transfer Using Placenta-On-A-Chip

News

Researchers have demonstrated the feasibility of their "organ-on-a-chip" platform in studying how drugs are transported across the human placental barrier.

READ MORE

'Click Chemistry' Reactions Could Boost Cancer-Fighting Drug Potency

News

Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties.

READ MORE

FoxO Proteins Implicated in Arthritis Age Risk

News

A study examining osteoarthritis has shown that as joints age, levels of FoxO decrease, causing pain and inflammation.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE